HLA class II alleles associated with infection by HPV16 in cervical cancer in situ

International Journal of Cancer

Volumn 93, Issue 6, 2001, Pages 817-822

  Beskow, Anna H ^a   Josefsson, Agnetha M ^a   Gyllensten, Ulf B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cervical cancer; HLA; HPV

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS; WART VIRUS;

ALLELES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENES, MHC CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; PAPILLOMAVIRIDAE; RISK; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0035885283     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1412     Document Type: Article

References (37)

1. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
3. Persistence of type-specific human papillomavirus infection among cytologically normal women
4. High risk of squamous cell carcinoma of the cervix for women with HLA- DQw3
5. Cervical carcinoma: Human papillomavirus infection and HLA-associated risk factors in the Spanish population
6. Association between HLA DQB1 * 03 and cervical intra-epithelial neoplasia
7. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women
8. HLA and susceptibility to cervical neoplasia
9. Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles
10. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity
11. An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: A population-based case-control study of Norwegian women
12. HPV 16 infection and progression of cervical intra-epithelial neoplasia: Analysis of HLA polymorphism and HPV 16 E6 sequence variants
13. Human papillomavirus type 16 E6 variants in cervical carcinoma: Relationship to host genetic factors and clinical parameters
14. Detection of genital human papillomavirus by single-tube nested PCR and type-specific oligonucleotide hybridization
15. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ
16. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ
17. Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay
18. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study
19. Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA
20. Rapid typing of DNA sequence polymorphism at the HLA-DRB1 locus using the polymerase chain reaction and nonradioactive oligonucleotide probes
21. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region
22. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families
23. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia
24. Different HLA DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women
25. HLA DQ-DR haplotype and susceptibility to cervical carcinoma: Indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18
26. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women
27. Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer
28. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix
29. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: Results from a case-control study conducted in the United States
30. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities
31. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: A nested case-control study
32. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer
33. Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden
34. Host factors and the pathogenesis of HIV-induced disease
35. Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans
36. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study
37. Natural HPV immunity and vaccination strategies